LYTIR

Company · ROIV

Roivant Sciences Ltd.

Nasdaq's symbol directory lists ROIV on Nasdaq as “Roivant Sciences Ltd. - Common Shares”.

In the 12 months to Nov 8, 2026: insiders sold on 30 occasions ($278.3M); 6 planned-sale notices; 3 filings by holders of 5% or more; 2 company reports (Form 8-K, since May 26, 2026).

All insider filings at the SEC · Appeared in No. 36, No. 32, No. 31, No. 30, No. 29, No. 19

Insider purchases and sales, by month (last 12 months)Insider purchases: $0 in total; Insider sales: $278.3M in total.Jun: Insider sales $196.8MJul: Insider sales $7.0MAug: Insider sales $43.7MSep: Insider sales $8.5MOct: Insider sales $15.0MNov: Insider sales $7.3MDecJanFebMarAprMayJunJulAugSepOctNov
Insider purchases above the line: $0Insider sales below: $278.3M
Dollar value of open-market purchases and sales reported on SEC Form 4, by the month traded. Sales include pre-arranged 10b5-1 plan sales.

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. Mayukh Sukhatme, President & CIO sold on 8 days latest Aug 21, 2026 sold $70.6M
  2. Keith S. Manchester sold on 3 days latest Jun 30, 2026 sold $56.4M
  3. Eric Venker, President & Immunovant CEO sold on 7 days all under a 10b5-1 plan latest Nov 3, 2026 sold $49.7M
  4. Daniel Allen Gold sold on 3 days latest Jun 30, 2026 sold $49.4M
  5. QVT Financial LP sold on 3 days latest Jun 30, 2026 sold $49.4M
  6. Melissa B. Epperly sold on 3 days all under a 10b5-1 plan latest Oct 1, 2026 sold $1.4M
  7. Meghan FitzGerald sold on 3 days all under a 10b5-1 plan latest Sep 15, 2026 sold $1.4M
Every trade (30)
  1. SELLEric Venker, President & Immunovant CEO sold Nov 3, 2026 200,000 shares 10b5-1 plan (scheduled) filing $7.3M
  2. SELLEric Venker, President & Immunovant CEO sold Oct 28, 2026 200,000 shares 10b5-1 plan (scheduled) filing $7.3M
  3. SELLEric Venker, President & Immunovant CEO sold Oct 20, 2026 200,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $7.0M
  4. SELLMelissa B. Epperly sold Oct 1, 2026 17,750 shares 2 legs combined 10b5-1 plan (scheduled) filing $641K
  5. SELLEric Venker, President & Immunovant CEO sold Sep 30, 2026 200,000 shares 10b5-1 plan (scheduled) filing $7.3M
  6. SELLMeghan FitzGerald sold Sep 15, 2026 5,112 shares 2 legs combined 10b5-1 plan (scheduled) filing $203K
  7. SELLMelissa B. Epperly sold Sep 15, 2026 4,938 shares 2 legs combined 10b5-1 plan (scheduled) filing $196K
  8. SELLMeghan FitzGerald sold Sep 8, 2026 20,000 shares 10b5-1 plan (scheduled) filing $798K
  9. SELLEric Venker, President & Immunovant CEO sold Aug 28, 2026 200,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $7.2M
  10. SELLMayukh Sukhatme, President & CIO sold Aug 21, 2026 144,756 shares filing $5.3M
  11. SELLMayukh Sukhatme, President & CIO sold Aug 20, 2026 17,519 shares filing $653K
  12. SELLMayukh Sukhatme, President & CIO sold Aug 19, 2026 172,899 shares filing $6.4M
  13. SELLMayukh Sukhatme, President & CIO sold Aug 18, 2026 136,942 shares 2 legs combined filing $5.0M
  14. SELLMayukh Sukhatme, President & CIO sold Aug 17, 2026 284,707 shares filing $10.3M
  15. SELLMayukh Sukhatme, President & CIO sold Aug 14, 2026 243,177 shares filing $8.8M
  16. SELLEric Venker, President & Immunovant CEO sold Jul 27, 2026 200,000 shares 10b5-1 plan (scheduled) filing $7.0M
  17. SELLKeith S. Manchester sold Jun 30, 2026 212,380 shares 2 legs combined filing $7.5M
  18. SELLDaniel Allen Gold sold Jun 30, 2026 12,380 shares filing $437K
  19. SELLQVT Financial LP sold Jun 30, 2026 12,380 shares filing $437K
  20. SELLMeghan FitzGerald sold Jun 30, 2026 10,000 shares 10b5-1 plan (scheduled) filing $349K
  21. SELLQVT Financial LP sold Jun 29, 2026 800,000 shares 2 legs combined filing $27.6M
  22. SELLDaniel Allen Gold sold Jun 29, 2026 800,000 shares 2 legs combined filing $27.6M
  23. SELLKeith S. Manchester sold Jun 29, 2026 800,000 shares 2 legs combined filing $27.6M
  24. SELLMelissa B. Epperly sold Jun 29, 2026 17,750 shares 2 legs combined 10b5-1 plan (scheduled) filing $610K
  25. SELLDaniel Allen Gold sold Jun 26, 2026 625,783 shares 2 legs combined filing $21.3M
  26. SELLKeith S. Manchester sold Jun 26, 2026 625,783 shares 2 legs combined filing $21.3M
  27. SELLQVT Financial LP sold Jun 26, 2026 625,783 shares 2 legs combined filing $21.3M
  28. SELLMayukh Sukhatme, President & CIO sold Jun 26, 2026 500,000 shares filing $17.0M
  29. SELLMayukh Sukhatme, President & CIO sold Jun 25, 2026 500,000 shares filing $17.1M
  30. SELLEric Venker, President & Immunovant CEO sold Jun 24, 2026 200,000 shares 2 legs combined 10b5-1 plan (scheduled) filing $6.6M

Planned sales · SEC Form 144

Notice given

A Form 144 is filed before an insider sells restricted stock. It states an intent; the sale, if it happens, appears later on a Form 4. Every recent notice

  1. Venker Eric filed Nov 3, 2026 Officer 200,000 shares planned sale date 11/03/2026 filing $7.3M
  2. Venker Eric filed Oct 28, 2026 Officer 200,000 shares planned sale date 10/28/2026 filing $7.3M
  3. Venker Eric filed Oct 20, 2026 Officer 200,000 shares planned sale date 10/20/2026 filing $7.0M
  4. Venker Eric filed Sep 30, 2026 Officer 200,000 shares planned sale date 09/30/2026 filing $7.3M
  5. MELISSA EPPERLY filed Sep 15, 2026 Director 22,688 shares planned sale date 09/15/2026 filing $931K
  6. MEGHAN FITZGERALD filed Sep 15, 2026 Officer 5,112 shares planned sale date 09/15/2026 filing $210K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. FMR LLC filed Nov 5, 2026 Schedule 13G/A passive 85,575,552 shares filing 11.8%
  2. BlackRock, Inc. filed Oct 27, 2026 Schedule 13G/A passive 59,285,183 shares filing 8.2%
  3. Morgan Stanley filed Aug 13, 2026 Schedule 13G/A passive filing 5.7%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Regulation FD disclosure filing Oct 21, 2026
  2. Submission of matters to a vote of security holders filing Sep 18, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.